fbpx

Clinical Studies

Colorectal Research Studies

With more than 1.9 million new colorectal cancer (CRC) cases and 935,173 deaths, CRC is the 3rd most common cancer in men and 2nd most common cancer in women. It is also 2nd leading cause of cancer deaths for men and women in the U.S.

Charter Research partners with people just like you to enhance the lives of our friends, neighbors, and future generations.

Do I qualify?

Each clinical study has its own set of criteria that a patient must meet in order to participate. The first step to find out if you or a loved one qualifies is to schedule a prescreen interview with one of our team members.

Types of Studies

What studies are available?

Below you’ll find the clinical trials that we’re currently enrolling patients in or will be soon.

View All Open Studies

Schedule a Prescreen

“Signal-C” Colorectal Cancer Test
We are validating Signal-C®, a blood-based diagnostic test to screen for colorectal cancer, in hopes this innovative new test may one day indicate if you need further evaluation.

Commitment to Your Care

Who will I be working with?

Participating in a clinical trial can feel intimidating at first. Put your mind at ease by getting to know some of our caring experts who’ll be working with you every step of the way.

Learn more about our Commitment to Care

Our Promise to You

What resources do you have for me?

We regularly share insights, tips, and new discoveries to provide you the latest on the diseases and chronic conditions you’re living with.

See all resources

Sign up to receive new Alzheimers research and resources.

Let us come to you. Sign up for our newsletter, and we’ll send updates right to your inbox.

Your information

This field is for validation purposes and should be left unchanged.